Mechanism of Yishen Xiezhuo Decoction in Treatment of Chronic Renal Failure by Inhibiting NKD2 Activity
-
摘要:
目的 通过建立慢性肾衰竭(CRF)小鼠模型, 以裸角质层同源物2(NKD2)为切入点, 观察益肾泻浊方对CRF小鼠各项肾功能指标的改善作用, 并初步探讨其作用机制。 方法 采用单侧输尿管梗阻法(UUO)构建小鼠CRF模型, 末次给药结束后处死小鼠, 观察测量小鼠肾脏形态和质量, HE和Masson染色观察肾脏病理情况, 使用肾小管损伤评分和肾纤维化区域量化指标评估肾衰竭程度。运用ELISA法测定血清中IL-1β、IL-6和TNF-α的水平, 试剂盒检测BUN和SCr水平。Western blot检测小鼠肾脏Collagen α1、FN1、α-SMA及NKD2蛋白含量。 结果 与正常组相比, 模型组小鼠肾脏组织出现水肿、颜色变浅、体积增大; 肾脏质量指数显著增加(P < 0.01), 肾小管损伤评分升高(P < 0.01), 肾纤维化水平和Collagen α1免疫组化表达量显著增加(P < 0.01);血清BUN、SCr、IL-6、IL-1β以及TNF-α水平均明显升高(P < 0.01);肾脏Collagen α1、FN1、α-SMA及NKD2蛋白表达量均增加(P < 0.01)。与模型组相比, 低剂量复方组小鼠肾小管损伤评分差异无统计学意义, 而肾脏质量指数(P < 0.01)、肾纤维化水平(P < 0.05)和Collagen α1免疫组化表达量(P < 0.05)均显著下降; 血清BUN、SCr、IL-6、IL-1β以及TNF-α水平均明显下降(P < 0.01), 肾脏Collagen α1、FN1、α-SMA及NKD2蛋白表达量显著减少(P < 0.01)。与模型组相比, 高剂量复方组小鼠肾脏质量指数、肾小管损伤评分和肾纤维化水平均明显减少(P < 0.01);血清BUN、SCr、IL-6、IL-1β以及TNF-α水平和肾脏Collagen α1、FN1、α-SMA及NKD2蛋白表达量均显著降低(P < 0.01)。 结论 益肾泻浊方能够下调NKD2表达, 减少肾脏ECM沉积, 抑制炎症反应, 从而延缓CRF进展。 Abstract:OBJECTIVE To observe the effect of Yishen Xiezhuo Decoction on various renal function indexes by establishing a mouse model of chronic renal failure (CRF) and explore the mechanism by taking naked stratum corneum homolog 2 (NKD2) as the breakthrough point. METHODS The CRF model of mice was established by unilateral ureteral obstruction (UUO). After the last administration, the mice were killed. The morphology and weight of the mouse kidneys were observed and measured. The renal pathology was observed by Hematoxylin-Eosin and Masson staining. The degree of renal failure was evaluated by renal tubular injury score and renal fibrosis area measurement. Serum IL-1β, IL-6 and TNF-α were determined by enzyme-linked immunosorbent assay (ELISA). The levels of BUN and SCr were detected by kits. Western blot was used to detect the protein expression of Collagen α1, FN1, α-SMA and NKD2. RESULTS Compared with the control group, the kidneys of the model group showed edema, reduced color and enlarged volume; renal mass index, renal tubular injury score, renal fibrosis area and Collagen α1 immunohistochemical expression increased significantly (P < 0.01). Serum levels of BUN, SCr, IL-6, IL-1β and TNF-α were increased significantly (P < 0.01), and the expression of kidney Collagen α1, FN1, α-SMA and NKD2 protein increased, too (P < 0.01). Compared with the model group, no significant difference was found on the scores of renal tubular injury in the low-dose group, but the renal weight index (P < 0.01), the level of renal fibrosis (P < 0.05) and the immunohistochemical expression of Collagen α1 (P < 0.05) decreased significantly. The levels of BUN, SCr, IL-6, IL-1β and TNF-α decreased significantly (P < 0.01), the protein expression of Collagen α1, FN1, α-SMA and NKD2 also decreased significantly (P < 0.01). Compared with the model group, the renal weight index, renal tubular injury scores and renal fibrosis area in the high-dose group were significantly reduced (P < 0.01); The levels of BUN, SCr, IL-6, IL-1β and TNF-α decreased significantly; the protein expression of kidney Collagen α1, FN1, α-SMA and NKD2 decreased significantly, too (P < 0.01). CONCLUSION Yishen Xiezhuo Decoction can down regulate the expression of NKD2, reduce the deposition of renal ECM, inhibit inflammatory responses, and delay the progress of CRF. -
图 1 各组小鼠肾脏形态和质量变化
注: 与Sham组相比, ##P < 0.01;与UUO组相比, **P < 0.01。x±s, n=9。
Figure 1. Changes in kidney morphology and weight of mice in each group
图 3 各组小鼠肾小管损伤评分、肾纤维化区域及Collagen α1表达量比较
注: 与Sham组相比, ##P < 0.01;与UUO组相比, *P < 0.05, **P < 0.01。x±s, n=9。
Figure 3. Comparison of renal tubule injury score, renal fibrosis area, and Collagen α1 expression in mice of each group
图 4 各组小鼠BUN和SCr水平比较
注: 与Sham组相比, ##P < 0.01;与UUO组相比, **P < 0.01。x±s, n=9。
Figure 4. Comparison of BUN and Scr levels of mice in each group
图 5 各组小鼠血清IL-6、IL-1β和TNF-α水平比较
注: 与Sham组相比, ##P < 0.01;与UUO组相比, **P < 0.01。x±s, n=9。
Figure 5. Comparison of IL-6, IL-1β and TNF-α levels of mice in each group
图 6 各组小鼠肾脏Collagen α1、FN1、α-SMA及NKD2蛋白表达量比较
注: 与Sham组相比, ##P < 0.01;与UUO组相比, **P < 0.01。x±s, n=9。
Figure 6. Comparison of renal Collagen α1, FN1, α-SMA and NKD2 protein expression in mice of each group
-
[1] ZHANG L, WANG F, WANG L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey[J]. Lancet, 2012, 379(9818): 815-822. doi: 10.1016/S0140-6736(12)60033-6 [2] HARRIS RC, NEILSON EG. Toward a unified theory of renal progression[J]. Annu Rev Med, 2006, 57: 365-380. doi: 10.1146/annurev.med.57.121304.131342 [3] ZEISBERG M, STRUTZ F, MÜLLER GA. Renal fibrosis: An update[J]. Curr Opin Nephrol Hypertens, 2001, 10(3): 315-320. doi: 10.1097/00041552-200105000-00004 [4] 齐振强, 任鲁颖, 冯国庆, 等. 慢性肾功能衰竭中医临床研究进展[J]. 中华中医药学刊, 2016, 34(8): 2006-2009. doi: 10.13193/j.issn.1673-7717.2016.08.062QI ZQ, REN LY, FENG GQ, et al. Research advances on traditional Chinese medicine clinical treatment for chronic renal failure[J]. Chin Arch Tradit Chin Med, 2016, 34(8): 2006-2009. doi: 10.13193/j.issn.1673-7717.2016.08.062 [5] 王钢, 邹燕勤, 周恩超. 邹云翔实用中医肾病学[M]. 北京: 中国中医药出版社, 2013.WANG G, ZOU YQ, ZHOU EC. Zou Yunxiang Practical Nephrology of Traditional Chinese Medicine[M]. Beijing: Chinese medicine press, 2013. [6] CHEN JW, HU YB, MOU X, et al. Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats[J]. Life Sci, 2021, 265: 118835. doi: 10.1016/j.lfs.2020.118835 [7] WU XH, LI H, WAN ZJ, et al. The combination of ursolic acid and empagliflozin relieves diabetic nephropathy by reducing inflammation, oxidative stress and renal fibrosis[J]. Biomed Pharmacother, 2021, 144: 112267. doi: 10.1016/j.biopha.2021.112267 [8] MENG XM, NIKOLIC-PATERSON DJ, LAN HY. TGF-β: The master regulator of fibrosis[J]. Nat Rev Nephrol, 2016, 12(6): 325-338. doi: 10.1038/nrneph.2016.48 [9] ROUSSET R, MACK JA, WHARTON KJ, et al. Naked cuticle targets dishevelled to antagonize Wnt signal transduction[J]. Genes Dev, 2001, 15(6): 658-671. doi: 10.1101/gad.869201 [10] ZHAO S, KURENBEKOVA L, GAO Y, et al. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma[J]. Oncogene, 2015, 34(39): 5069-5079. doi: 10.1038/onc.2014.429 [11] KUPPE C, IBRAHIM MM, KRANZ J, et al. Decoding myofibroblast origins in human kidney fibrosis[J]. Nature, 2021, 589(7841): 281-286. doi: 10.1038/s41586-020-2941-1 [12] CHEN DQ, CAO G, CHEN H, et al. Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan[J]. Nat Commun, 2019, 10(1): 1476. doi: 10.1038/s41467-019-09329-0 [13] SONG J, XIA YY, YAN X, et al. Losartan accelerates the repair process of renal fibrosis in UUO mouse after the surgical recanalization by upregulating the expression of Tregs[J]. Int Urol Nephrol, 2019, 51(11): 2073-2081. doi: 10.1007/s11255-019-02253-8 [14] YANG K, LI W, BAI T, et al. Mindin deficiency alleviates renal fibrosis through inhibiting NF-κB and TGF-β/Smad pathways[J]. J Cell Mol Med, 2020, 24(10): 5740-5750. doi: 10.1111/jcmm.15236 [15] PAN Z, YANG K, WANG HB, et al. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways[J]. FASEB J, 2020, 34(11): 14250-14263. doi: 10.1096/fj.202001026R [16] LI HP, FENG YB, SUN WX, et al. Antioxidation, anti-inflammation and anti-fibrosis effect of phosphorylated polysaccharides from Pleurotus djamor mycelia on adenine-induced chronic renal failure mice[J]. Int J Biol Macromol, 2021, 170: 652-663. doi: 10.1016/j.ijbiomac.2020.12.159 [17] LEMOS DR, MCMURDO M, KARACA G, et al. Interleukin-1β activates a MYC-dependent metabolic switch in kidney stromal cells necessary for progressive tubulointerstitial fibrosis[J]. J Am Soc Nephrol, 2018, 29(6): 1690-1705. doi: 10.1681/ASN.2017121283 [18] MERAN S, STEADMAN R. Fibroblasts and myofibroblasts in renal fibrosis[J]. Int J Exp Pathol, 2011, 92(3): 158-167. doi: 10.1111/j.1365-2613.2011.00764.x [19] YUAN Q, TAN RJ, LIU YH. Myofibroblast in kidney fibrosis: Origin, activation, and regulation[J]. Adv Exp Med Biol, 2019, 1165: 253-283. [20] MOERMAN T, AIBAR SANTOS S, BRAVO GONZALEZ-BLAS C, et al. GRNBoost2 and Arboreto: Efficient and scalable inference of gene regulatory networks[J]. Bioinformatics, 2019, 35(12): 2159-2161. doi: 10.1093/bioinformatics/bty916 -
下载:
点击查看大图
图(7)
计量
- 文章访问数: 164
- HTML全文浏览量: 21
- PDF下载量: 19
- 被引次数: 0
